Site Search

Share

X

Search Results

Access to Biomarker Testing

Biomarker testing is key to unlocking precision medicine.   Biomarkers are often used to help determine the best treatment for a patient, but not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. Access to Biomarker Testing ...

Cancer Biomarker Testing

... cancer therapies that have improved patient outcomes and quality of life within populations of cancer patients with very specific biomarkers. Testing patients for cancer biomarkers is integral to identify those who may benefit from targeted therapy. Despite the importance of such testing, ... advancements in targeted cancer therapies and data from ACS CAN Survivor Views surveys of cancer patients and survivors assessing barriers to biomarker testing.   Cancer Biomarker Testing ...

Biomarker Testing in Tennessee

Sign our petition to expand access to biomarker testing in Tennessee! Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Tennessee ...

Access to Biomarker Testing

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Massachusetts residents can benefit from this important testing. Not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Communities that have been excluded, including communities of color, individuals with lower socioeconomic ...

Biomarker Testing – Partner Briefing

Biomarker Testing – Partner Briefing ...

Increasing Access to Biomarker Testing

Specialized testing can help doctors ensure they are getting the right treatment to the right patient at the right time -- but not everyone has access. This testing, called “biomarker testing”, identifies markers or mutations in a patient’s cancer cells. The results of biomarker tests can help determine the best treatment plan for a specific patient, leading to improved survivorship and better quality of life. ...

Biomarker Testing and Cost Savings

Biomarker Testing and Cost Savings Timely access to guideline-indicated comprehensive biomarker testing can help achieve the triple aim of health care including better health outcomes, improved quality of life, and reduced costs. Comprehensive ...

New York Biomarker Testing Campaign

Welcome! Precision medicine is changing the way we treat cancer. Biomarker testing is the key to unlocking access to these personalized treatments. ACS CAN and partners are working together to make sure more New Yorkers have access to the right medicine at the right time. Ask Governor Hochul to Sign the New York Biomarker Bill Without Delay Please send a message to Governor Hochul today and implore her to sign our bill the minute it hits her desk! New ...

Improving Access to Biomarker Testing

... led to targeted cancer therapies that can improve patient survival and quality life. Treatment with targeted therapy often requires diagnostic testing to analyze biological samples taken from patients to identify and evaluate cancer biomarkers. Testing patients for specific biomarkers is integral to precision medicine in cancer care, but despite evidence pointing to the clinical benefits associated with biomarker testing, routine clinical use does not always follow, and testing rates lag behind clinical guideline recommendations. As highlighted in a recent ACS CAN survey of cancer patients and survivors, only one-third of respondents reported having biomarker testing. Of those who reported not receiving biomarker testing, more than a quarter said it was because insurance would not cover it or ...

Impact of Comprehensive Biomarker Testing

Illustrative stories about the impact of timely testing and the importance of insurance coverage for comprehensive biomarker testing – not only to improve patient outcomes and quality of life but also to avoid ineffective treatments and disease progression. Impact of Comprehensive Biomarker Testing ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy